50 percent of patients hospitalized with COVID-19 and 19 percent of asymptomatic patients had at least one post-COVID-19 condition
Wide variation seen in continuity of nursing staff for home health care visits to dementia patients following hospitalization
However, opioids still commonly dispensed, with high-risk prescribing practices suspected in young children
Increased in-hospital mortality for COVID-19 patients with schizophrenia versus those without severe mental illness
Donanemab has already received a 'breakthrough therapy' designation from the FDA
Donanemab has already received a 'breakthrough therapy' designation from the FDA
Odds ratios for adverse mental health symptoms, especially suicidal ideation, highest for those in both roles
Incidence of dementia increased at age 66 and 80 years for those with schizophrenia versus those without serious mental illness
Odds ratios for adverse mental health symptoms, especially suicidal ideation, highest for those in both roles